PYODERMA

Clinical trials for PYODERMA explained in plain language.

Never miss a new study

Get alerted when new PYODERMA trials appear

Sign up with your email to follow new studies for PYODERMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug test aims to heal painful, Hard-to-Treat skin wounds

Disease control Recruiting now

This study is testing whether a medication called guselkumab can help heal painful skin ulcers caused by pyoderma gangrenosum, a rare inflammatory skin condition. Seventeen adult participants will receive guselkumab injections every four weeks along with a stable daily dose of pr…

Matched conditions: PYODERMA

Phase: PHASE2 • Sponsor: Oregon Health and Science University • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

PYODERMA

Get alerted when new PYODERMA trials appear

New drug test aims to heal painful, Hard-to-Treat skin wounds